Publication | Open Access
A New Advanced<scp>MRI</scp>Biomarker for Remyelinated Lesions in Multiple Sclerosis
80
Citations
55
References
2022
Year
These results provide the first evidence that it is possible to distinguish chronic MS lesions in a clinical setting, hereby supporting with new biomarkers to develop and assess remyelinating treatments. ANN NEUROL 2022;92:486-502.
| Year | Citations | |
|---|---|---|
Page 1
Page 1